Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.
Anti-phospholipid (aPL) antibodies are important contributors to development of thrombosis in patients with the autoimmune rheumatic disease systemic lupus erythematosus (SLE). The underlying mechanism of aPL antibody-mediated thrombosis is not fully understood but existing data suggest that platele...
Main Authors: | Christian Lood, Helena Tydén, Birgitta Gullstrand, Gunnar Sturfelt, Andreas Jönsen, Lennart Truedsson, Anders A Bengtsson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24922069/?tool=EBI |
Similar Items
-
Low Intra-Individual Variation in Mean Platelet Volume Over Time in Systemic Lupus Erythematosus
by: Lina Wirestam, et al.
Published: (2021-04-01) -
Low plasma concentrations of apolipoprotein M are associated with disease activity and endothelial dysfunction in systemic lupus erythematosus
by: Helena Tydén, et al.
Published: (2019-05-01) -
Neutrophil FcγRIIA availability is associated with disease activity in systemic lupus erythematosus
by: Anders A. Bengtsson, et al.
Published: (2020-05-01) -
Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus.
by: Christian Lood, et al.
Published: (2015-01-01) -
Platelets and the Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus or Antiphospholipid Syndrome
by: Signe Risbøl Vils, et al.
Published: (2023-04-01)